Judson Taylor
Technik-/Wissenschafts-/F&E-Leiter bei DIANTHUS THERAPEUTICS, INC.
Profil
Judson Taylor's current job is as the Head-Technical Operations at Dianthus Therapeutics, Inc. Mr. Taylor's former jobs include being the Vice President-Technical Operations at Radius Health, Inc. from 2018 to 2022, and the Vice President-Supply Chain at Synergy Pharmaceuticals LLC from 2015 to 2018.
Mr. Taylor's education includes an MBA degree from Temple University (Pennsylvania) and an undergraduate degree from The Pennsylvania State University.
Aktive Positionen von Judson Taylor
| Unternehmen | Position | Beginn |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 11.09.2023 |
Ehemalige bekannte Positionen von Judson Taylor
| Unternehmen | Position | Ende |
|---|---|---|
| RADIUS HEALTH, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2022 |
| SYNERGY PHARMACEUTICALS INC | Corporate Officer/Principal | 01.08.2018 |
Ausbildung von Judson Taylor
| Temple University (Pennsylvania) | Masters Business Admin |
| The Pennsylvania State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DIANTHUS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |